IGC Pharma, Inc.
IGC- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001326205
No open-market purchases or sales by IGC Pharma, Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $1.41M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in IGC Pharma, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- 0 vs. Q1 2024
- Shares held
- 2.56M
- +204.0K (+8.7%) vs. Q1 2024
- Total value
- $1.11M
- +$166.6K (+17.7%) vs. Q1 2024
- New holders
- 5
- 4 more added
- Sold out
- 5
- 6 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IGC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 36 | $1.41M |
| Q1 2026 | 35 | $1.14M |
| Q4 2025 | 30 | $1.36M |
| Q3 2025 | 35 | $2.27M |
| Q2 2025 | 28 | $929.4K |
| Q1 2025 | 25 | $814.9K |
| Q4 2024 | 30 | $954.3K |
| Q3 2024 | 23 | $1.19M |
| Q2 2024 | 25 | $1.11M |
| Q1 2024 | 25 | $943.4K |
| Q4 2023 | 25 | $691.3K |
| Q3 2023 | 27 | $1.01M |
| Q2 2023 | 23 | $827.5K |
| Q1 2023 | 23 | $917.6K |
| Q4 2022 | 26 | $937.3K |
| Q3 2022 | 26 | $1.31M |
| Q2 2022 | 29 | $1.73M |
| Q1 2022 | 29 | $3.97M |
| Q4 2021 | 29 | $6.07M |
| Q3 2021 | 32 | $7.90M |
| Q2 2021 | 29 | $7.90M |
| Q1 2021 | 29 | $7.97M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding IGC Pharma, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock Inc. | 703,798 | $305.3K | 0.00% | −11,642−1.6% | Reduced |
| Vanguard Group Inc | 645,166 | $279.9K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 429,827 | $186.5K | 0.00% | +105,531+32.5% | Added |
| State Street Corp | 165,307 | $71.7K | 0.00% | +45,600+38.1% | Added |
| Susquehanna International Group, LLP | 152,376 | $66.1K | 0.00% | +152,376 | New |
| Dearborn Partners LLC | 116,401 | $50.5K | 0.00% | −309−0.3% | Reduced |
| Northern Trust Corp | 71,027 | $30.8K | 0.00% | −337−0.5% | Reduced |
| Goldman Sachs Group Inc | 65,495 | $28.4K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 46,497 | $20.0K | 0.00% | +46,497 | New |
| Truist Financial Corp | 36,667 | $15.9K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 34,600 | $15.0K | 0.00% | +34,600 | New |
| Two Sigma Securities, LLC | 33,605 | $14.6K | 0.00% | +17,168+104.4% | Added |
| Group One Trading, L.P. | 22,117 | $9.59K | 0.00% | −15,189−40.7% | Reduced |
| Jane Street Group, LLC | 22,060 | $9.57K | 0.00% | +7,484+51.3% | Added |
| Tower Research Capital LLC (TRC) | 8,018 | $3.48K | 0.00% | −5,636−41.3% | Reduced |
| Geneos Wealth Management Inc. | 3,000 | $1.29K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 860 | $373 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 800 | $344 | 0.00% | 00.0% | Unchanged |
| CIBC Private Wealth Group, LLC | 655 | $270 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 417 | $181 | 0.00% | +417 | New |
| Caitlin John, LLC | 200 | $87 | 0.00% | 00.0% | Unchanged |
| DHJJ Financial Advisors, Ltd. | 80 | $35 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 36 | $15 | 0.00% | −2,715−98.7% | Reduced |
| Toronto Dominion Bank | 6 | $3 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 2,012 | $0 | 0.00% | +2,012 | New |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −141,303−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −29,272−100.0% | Sold out |
| Central Trust Co | 0 | $0 | 0.00% | −900−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −379−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −25−100.0% | Sold out |